GlassScriptPhysician profile
Jeffrey Lee Caylor
NPI 1730153271
$37,382.10
in general payments reported to CMS, 2019-2025
10 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $4,472 · 2021: $359 · 2022: $1,366 · 2023: $8,380 · 2024: $99.38 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $694.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36,744.70 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $337.81 | 2020-2024 | Channel Drain |
| Myriad Genetic Laboratories, INC. | $88.10 | 2021 | |
| Tela Bio, INC. | $83.83 | 2021-2024 | Ovitex 2s |
| Becton, Dickinson and Company | $38.07 | 2024 | Arista Ah Flexitip |
| Baxter Healthcare | $25.00 | 2021 | |
| Standard Bariatrics, INC. | $18.83 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.35 | 2021 | |
| Hologic Sales and Service, LLC | $14.71 | 2025 | Brevera Breast Biopsy System, Aixplorer Ultimate |
| Teleflex LLC | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Caylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.